These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8393677)

  • 1. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus.
    Aderka D; Wysenbeek A; Engelmann H; Cope AP; Brennan F; Molad Y; Hornik V; Levo Y; Maini RN; Feldmann M
    Arthritis Rheum; 1993 Aug; 36(8):1111-20. PubMed ID: 8393677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus.
    Davas EM; Tsirogianni A; Kappou I; Karamitsos D; Economidou I; Dantis PC
    Clin Rheumatol; 1999; 18(1):17-22. PubMed ID: 10088943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
    Wais T; Fierz W; Stoll T; Villiger PM
    J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
    Svenungsson E; Gunnarsson I; Fei GZ; Lundberg IE; Klareskog L; Frostegård J
    Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy, cytokines, and disease activity in systemic lupus erythematosus.
    Doria A; Ghirardello A; Iaccarino L; Zampieri S; Punzi L; Tarricone E; Ruffatti A; Sulli A; Sarzi-Puttini PC; Gambari PF; Cutolo M
    Arthritis Rheum; 2004 Dec; 51(6):989-95. PubMed ID: 15593367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schönlein purpura and pediatric systemic lupus erythematosus.
    Gattorno M; Vignola S; Barbano G; Sormani MP; Sabatini F; Buoncompagni A; Picco P; Pistoia V
    J Rheumatol; 2000 Sep; 27(9):2251-5. PubMed ID: 10990243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentrations of tumour necrosis factor-alpha (TNF-alpha) and soluble TNF-alpha receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function.
    Díez JJ; Hernanz A; Medina S; Bayón C; Iglesias P
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):515-21. PubMed ID: 12354134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin reduced soluble receptors of TNF-alpha in systemic lupus erythematosus.
    Ferreira GA; Teixeira AL; Calderaro DC; Sato EI
    Clin Exp Rheumatol; 2016; 34(1):42-8. PubMed ID: 26574625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up regulation of serum tumor necrosis factor-related apoptosis inducing ligand in juvenile-onset systemic lupus erythematosus: relations with disease activity, antibodies to double -stranded DNA, nephritis and neutropenia.
    Ezzat MH; El-Gammasy TM; Shaheen KY; El-Mezdawi RA; Youssef MS
    Int J Rheum Dis; 2013 Jun; 16(3):310-8. PubMed ID: 23981753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in tumor necrosis factor-alpha soluble receptor serum concentrations between patients with Henoch-Schönlein purpura and pediatric systemic lupus erythematosus: pathogenetic implications.
    Gattorno M; Picco P; Barbano G; Stalla F; Sormani MP; Buoncompagni A; Gusmano R; Borrone C; Pistoia V
    J Rheumatol; 1998 Feb; 25(2):361-5. PubMed ID: 9489835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between soluble tumor necrosis factor (TNF) receptors and TNF alpha during immunotherapy with interleukin-2 and/or interferon alpha.
    Landmann R; Keilholz U; Scheibenbogen C; Brockhaus M; Gallati H; Denz H; Bargetzi M; Ludwig C
    Cancer Immunol Immunother; 1994 Feb; 38(2):113-8. PubMed ID: 8306366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
    Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
    J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
    Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
    Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.
    Draborg AH; Lydolph MC; Westergaard M; Olesen Larsen S; Nielsen CT; Duus K; Jacobsen S; Houen G
    PLoS One; 2015; 10(9):e0138753. PubMed ID: 26402865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic Lupus Erythmatosus is Associated with Disturbed Cytokine Milieu and Increased TNF-Related Apoptosis-Induced Ligand Levels.
    Saeed AM; Mogahed MM
    Egypt J Immunol; 2016 Jun; 23(2):75-85. PubMed ID: 28502135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
    Morel J; Roubille C; Planelles L; Rocha C; Fernandez L; Lukas C; Hahne M; Combe B
    Ann Rheum Dis; 2009 Jun; 68(6):997-1002. PubMed ID: 18676986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated plasma levels of soluble tumor necrosis factor receptor (sTNFRp60) reflect severity of acute pancreatitis.
    Kaufmann P; Tilz GP; Lueger A; Demel U
    Intensive Care Med; 1997 Aug; 23(8):841-8. PubMed ID: 9310801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressive symptoms are associated with tumor necrosis factor alpha in systemic lupus erythematosus.
    Postal M; Lapa AT; Sinicato NA; de Oliveira Peliçari K; Peres FA; Costallat LT; Fernandes PT; Marini R; Appenzeller S
    J Neuroinflammation; 2016 Jan; 13():5. PubMed ID: 26732584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.